Gilead Sciences Inc on Tuesday announced a strategic collaboration with Genesis Therapeutics Inc to discover and deve ...
Gilead Sciences Inc on Thursday said that the marketing authorisation in Japan for its chimeric antigen receptor T-ce ...
The following is a round-up of updates by global companies, issued on Tuesday and not separately reported by Alliance ...
The World Health Organization said Friday it "strongly recommended" Pfizer Inc's covid-19 antiviral pill Paxlovid for ...
GlaxoSmithKline PLC on Wednesday said majority-owned investee ViiV Healthcare has agreed to settle a global patent in ...
Gilead Sciences Inc on Friday said that the US Food & Drug Administration granted its Veklury drug expedited approval ...
Gilead Sciences Inc and Merck & Co Inc announced Tuesday the start of a Phase 2 clinical study evaluating an investig ...
Gilead Sciences Inc on Tuesday said it has entered into a clinical collaboration with Vir Biotechnology Inc focused o ...
Gilead Sciences Inc on Monday said it has increased its product sales guidance for 2020 as one of its drugs used to t ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.94 | 1.07049311012 | 87.81 | 89.24 | 85.25 | 3392 | 87.76786287 | DE |
4 | 2.88 | 3.35390706882 | 85.87 | 90.44 | 85.25 | 5411 | 88.3140892 | DE |
12 | 14.3 | 19.2075218267 | 74.45 | 92.77 | 73.92 | 5753 | 84.96537379 | DE |
26 | 29.76 | 50.4492286828 | 58.99 | 92.77 | 58.53 | 5187 | 76.71805997 | DE |
52 | 16.37 | 22.6167449572 | 72.38 | 92.77 | 57.18 | 5255 | 72.07549966 | DE |
156 | 25.45 | 40.205371248 | 63.3 | 92.77 | 52.06 | 4419 | 70.79793623 | DE |
260 | 30.34 | 51.9431604177 | 58.41 | 92.77 | 46.165 | 10768 | 65.42179091 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.